NCT00001427已完成2 期
A Phase II Trial of 72-Hour Continuous IV Infusion of 9-Aminocamptothecin With G-CSF Support in Patients With Advanced Ovarian Cancer Previously Treated With Paclitaxel and Cisplatin
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
- 试验地点
- 2
研究概览
简要总结
The objectives of this study are to determine the response rate to 9-AC in patients with advanced ovarian cancer who have recurrent disease after paclitaxel- and cisplatin-based chemotherapy regimens.
详细描述
This is a Phase II study of 9-aminocamptothecin (9-AC), administered as an intravenous continuous infusion over 72 hours with G-CSF support for patients with advanced refractory ovarian cancer. The objectives of the present study are to determine the response rate to 9-AC in patients with advanced ovarian cancer who have recurrent disease after paclitaxel- and cisplatin-based chemotherapy regimens.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
Modified Hyper-CVAD (Cyclophosphamide, Vincristine, Adriamycin, and Dexamethasone) Program for Acute Lymphoblastic LeukemiaLeukemiaAcute Lymphoblastic LeukemiaNCT00671658M.D. Anderson Cancer Center220
已完成
2 期
Treatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's SarcomaKaposi's SarcomaNCT01067690Barbara Ensoli, MD, PhD25
已完成
不适用
Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin)Genital EndometriosisNCT01294371AbbVie (prior sponsor, Abbott)391
Unknown
3 期
Standard High-Dose Alpha Interferon Versus Intermittent High-Dose Alpha InterferonAdjuvantStage III Malignant MelanomaInterferon AlphaTherapyNCT00226408Dermatologic Cooperative Oncology Group600
已完成
2 期
Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver MetsPancreatic CancerLiver CancerNCT01581307H. Lee Moffitt Cancer Center and Research Institute9